Tirofiban Hydrochloride Injection, Solution
Product Images NDC 68083-145

This is a medication called Tirofiban Hydrochloride Injection, which is recommended for use with a calibrated infusion device. Each container contains 250ml of sterile, nonpyrogenic solution with a concentration of 12.5mg of Tirofiban Hydrochloride, 2.25g of Sodium Chloride, 135mg of Sodium Citrate Dihydrate, and other chemicals. The dosage is administered intravenously as directed by a physician. The container should be checked for minute leaks before use and must be discarded if any leaks are found for the sake of sterility. This medication should not be used if the solution is not clear. The proper storage of this product is required in a controlled room temperature environment without freezing and exposure to light. Manufacturing details and an item code are also available.*

This is a description of Tirofiban Hydrochloride Injection, which is a medication administered intravenously as directed by a physician. It is recommended to be used with a calibrated infusion device and comes in a single-dose container. Each 250 mL contains Tirofiban hydrochloride, sodium chloride, sodium citrate dihydrate, citric acid anhydrous, and water for injection. The usual dosage is 12.5mg per 250mL, intravenously, as directed by a physician. It should not be used in series connections and supplemental medication should not be added. It is important to check for minute leaks by squeezing the container firmly as leaks can impair sterility. The medication must be stored at 25°C (77°F) and protected from light. The 2D barcode includes batch details and Gland Item Code.*

Tirofiban Hydrochloride Injection is a sterile nonpyrogenic iso-osmotic single-dose container used intravenously and contains Tirofiban hydrochloride. Each 250 mL bag contains 12.5 mg tirofiban, 2.25 g sodium chloride, 135 mg sodium citrate dihydrate, 8 mg citric acid anhydrous, Water for Injection. It is recommended not to use supplementary medication and to check for minute leaks before using the injection. It is cautioned not to use in series connections and not to use unless the solution is clear. It is recommended to store the injection at 25°C and protect it from light during storage. The manufacturing of Tirofiban Hydrochloride Injection is done by GLAND PHARMA LIMITED in India. Batch details & 2D Barcode can be printed on the unvarnished area.*

The given text is a medical prescription for administering medication. It recommends taking 25 milligrams of medication per kilogram of body weight for the patient. The Bolus Volume at L is not available due to incomplete information. The concentration of the medication is 50 milligrams per milliliter.*

This text provides calculations for infusion rates based on body weight and creatinine clearance (CrCl). The first formula calculates the infusion rate at 0.15 mg/kg/min multiplied by body weight in kg and 60 minutes per hour, but it does not provide a context for the specific medication being infused. The second formula calculates the infusion rate in mL/hour for a medication with a concentration of 50 mg/mL, but does not provide any additional information about the medication or the patient population.*

This appears to be a calculation to determine the infusion rate for a medication based on the patient's weight and kidney function. The medication concentration is given as 50 meg/mL, and the infusion rate for a patient with a creatinine clearance greater than 60 mL/min is calculated to be 10.8 mL/hour.*

This text provides a formula to calculate the infusion rate for patients with creatinine clearance (CrCl) less than 60 mL/min. The formula involves multiplying a constant (0.075 meg/kg/min) with the patient's body weight in kg and 60 min/h, and then dividing the result by 50 meg/mL. The output of this equation gives the infusion rate in mL/h.*